Combination of Selective ALK Inhibitor ASP3026 with Inhibition of IGF-1R Signaling Overcomes Crizotinib Resistance in NCI-H2228 Human NSCLC Cells

European Journal of Cancer(2012)

Cited 0|Views6
No score
Key words
selective alk inhibitor asp3026,nsclc
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined